STU:LIK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STU:LIK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Limes Schlosskliniken AG's enterprise value is €94.07 Mil. Limes Schlosskliniken AG's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €41.78 Mil. Therefore, Limes Schlosskliniken AG's EV-to-Revenue for today is 2.25.
The historical rank and industry rank for Limes Schlosskliniken AG's EV-to-Revenue or its related term are showing as below:
During the past 7 years, the highest EV-to-Revenue of Limes Schlosskliniken AG was 5.80. The lowest was 2.34. And the median was 3.20.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-11-14), Limes Schlosskliniken AG's stock price is €322.00. Limes Schlosskliniken AG's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €142.60. Therefore, Limes Schlosskliniken AG's PS Ratio for today is 2.26.
The historical data trend for Limes Schlosskliniken AG's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Limes Schlosskliniken AG Annual Data | ||||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
EV-to-Revenue | Get a 7-Day Free Trial | 3.07 | 2.82 | 2.66 | 3.19 | 2.32 |
Limes Schlosskliniken AG Semi-Annual Data | ||||||||||||||
Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | |
EV-to-Revenue | Get a 7-Day Free Trial | - | 3.19 | - | 2.32 | - |
For the Medical Care Facilities subindustry, Limes Schlosskliniken AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Limes Schlosskliniken AG's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Limes Schlosskliniken AG's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Limes Schlosskliniken AG's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 94.074 | / | 41.781 | |
= | 2.25 |
Limes Schlosskliniken AG's current Enterprise Value is €94.07 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Limes Schlosskliniken AG's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €41.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Limes Schlosskliniken AG (STU:LIK) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Limes Schlosskliniken AG's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 322.00 | / | 142.598 | |
= | 2.26 |
Limes Schlosskliniken AG's share price for today is €322.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was €142.60.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Limes Schlosskliniken AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.